METHODOLOGY WALKTHROUGH: FOR EDUCATIONAL DEMONSTRATION ONLY. NOT INVESTMENT ADVICE.

DIVISLABPharmaPharma/API Structural Model
15th April 2026

Divi's Laboratories

We track 12 quarters of structural velocity to detect systemic stress that may not yet be reflected in market valuation metrics.

Peak Risk Score
42/ 100
Scale: 0 = Clean • 100 = Severe Risk (Lower is safer)
Risk ClassModerate Risk
Peak Valuation—Pre-Crisis High
Trough / Resolution—Post-Default Market
Default Exposure—Admitted Claims
Flagium Risk Score (Left Axis: 0–100)
Multi-Quarter Risk vs. Stock Trajectory
0255075100Elevated Risk Threshold (65)Moderate Band (45)Q1Q2Q3Q4Q5Q6Q7Q8Q9Q10Q11Q12FlagiumAI • Systematic Corporate Health Monitoring (flagiumai.com)
Systematic Watermark: FlagiumAI • Systematic Corporate Health Monitoring
•

Structural risk reflects underlying balance sheet trends over a multi-quarter window.

Key Engine Signals & Trigger Factors

Primary forensic signals contributing to the 42/100 peak risk score

Signal Attribution
✕

Asset Turnover Decay

Revenue per unit of new Capex is slowing down.

✓

Zero Compliance Stress

Perfect FDA audit record across all manufacturing units.

✓

High Margin Resilience

API pricing power prevents deep score escalation.

✕

Working Capital Load

High inventory days due to logistical strategy.

Forensic Pillar Evaluation

Status across all 6 core analysis pillars in the sector model.

03. Solvency (Capex)Elevated

Heavy Capex build not yet yielding proportional revenue.

04. Specialized (Pharma)Stable

Compliance and quality records remain clean.

01. Earnings QualityStable

Cash conversion remains above sector median.

02. LiquidityStable

Zero structural debt on the balance sheet.

05. Sector RelativeStable

Leading margins in the global API space.

06. GovernanceStable

High-grade disclosures with promoter transparency.

Key Trigger Signals & Disclosures

Algorithmic trigger conditions and statutory data points.

Pillar 3: Solvency (Capex)

TRIGGERED

Capex Efficiency Lag

Trigger Condition:

Revenue / Gross Block < 1.2x

In asset-heavy Pharma, the engine flags when billion-dollar capacities don't translate to top-line growth.

Filing Source:Audited Annual Reports
#Fixed Asset Turnover#CWIP

Forensic Analysis Takeaway

Key Lesson for Institutional & Public Investors

"The moderate score reflects an 'Efficiency Gap' (Pillar 3) where the company is in a heavy investment phase before the revenue-velocity of new assets matures."

Evaluated by Flagium Quantitative EWS Backtest Engine

Live Systematic Surveillance

Monitor 3,000+ Listed Indian Equities for Early Forensic Anomalies

FlagiumAI continuously scans active NSE & BSE quarterly results, XBRL filings, and balance sheet disclosures using these deterministic rule engines.

Run an Equities Health Check →
EWS Engineering & Methodology

Explore the Forensic Methodology Behind the EWS Score

Discover how Flagium's 6-pillar framework, 29 forensic flags, sector capacity models, and interaction multipliers quantify balance sheet stress and credit deterioration across Indian equities.